Study of a new medicine for Behçet's disease mouth ulcers
Treatments studied
Part of Immune system & allergy clinical trials.
This trial tests a new medicine, HSK44459, to see if it can reduce mouth ulcers in people with Behçet's disease. If you have frequent mouth sores from Behçet's, this treatment might help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with Behçet's disease.
- You have had at least 3 episodes of mouth ulcers in the past year.
- You have at least 2 mouth ulcers now.
- You have taken medicine for Behçet's disease before.
- Your doctor says you need treatment for mouth ulcers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new pill called Hemay005 for adults with Behçet's disease who have at least two mouth sores that need treatment beyond creams or rinses. It aims to see if the drug safely reduces mouth ulcers.
This study is for people with Behçet's disease who have already taken the study medicine (HSK44459) in an earlier trial. It continues to check how safe and effective the medicine is over a longer time.
This study tests a medication called corticotropin (a hormone that may help control inflammation) to see if it can reduce symptoms of Behçet's disease, especially painful mouth ulcers. If you have active ulcers, this treatment might help you get relief.
This trial studies lenalidomide to treat frequent, ongoing mouth ulcers caused by mucosal Behçet’s syndrome. It’s meant for people whose mouth sores keep coming back despite standard treatments like steroid medicines and other immune-suppressing drugs.
This study tests if ustekinumab or apremilast can help control Behçet's disease symptoms like mouth and genital ulcers, skin sores, and joint pain. It may be an option if standard treatments haven't worked well.
This study tests apremilast to help reduce active, recurring mouth (oral) ulcers in children with Behçet’s disease. It may help if your child has had repeated mouth ulcers despite at least one non-biologic treatment.
Hear when a new Behcet's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.